US Stock MarketDetailed Quotes

KMPH KemPharm

Watchlist
  • 5.810
  • 0.0000.00%
15min DelayTrading Feb 28 16:00 ET
200.47MMarket Cap-6528P/E (TTM)

KemPharm Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

KemPharm Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 31.058M--
--2024/Q4-- / 8.776M--
--2024/Q33.695M / 4.863M--
--2024/Q24.449M / 4.358M--
--2024/Q13.425M / 3.759M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 31.058M--
--2024/Q4-- / 8.776M--
--2024/Q33.695M / 4.863M--
--2024/Q24.449M / 4.358M--
--2024/Q13.425M / 3.759M--

Unlock Free Earnings Estimates

KemPharm Earnings Reports

  • 10-Q: Q3 2024 Earnings Report

    Nov 13 16:24 ET

  • 8-K: Zevra Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Updates

    Nov 12 16:29 ET

  • 10-Q: Q2 2024 Earnings Report

    Aug 14 14:30 ET

  • 8-K: Zevra Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights

    Aug 13 16:24 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data